DBV Technologies S.A. ADR (DBVT)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE, FRANCE 92120

DBV Technologies SA operates as a biopharmaceutical firm. The Company develops products and immunotherapies for the diagnosis and treatment of various food allergies. DBV Technologies delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin.

Data based on most recent fiscal year report
Market Cap1.136 Billion Shares Outstanding91.28 Million Avg Volume419.937 Thousand
1-Yr BETA vs S&P TR0.208 Current Ratio3.34 Quick Ratio3.31
View SEC Filings from DBVT instead.

Funds Holding DBVT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DBVT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments